As of 2026-03-19, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -1.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 14.47 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -12.96 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.3x - 21.9x | 14.4x |
| Forward P/E multiples | 13.1x - 18.3x | 15.3x |
| Fair Price | (2.21) - (3.18) | (2.54) |
| Upside | -674.6% - -925.8% | -759.8% |
| Date | EV/EBITDA |
| 2026-03-17 | -1.11 |
| 2026-03-16 | -1.13 |
| 2026-03-13 | -1.11 |
| 2026-03-12 | -1.13 |
| 2026-03-11 | -1.11 |
| 2026-03-10 | -1.11 |
| 2026-03-09 | -1.12 |
| 2026-03-06 | -1.11 |
| 2026-03-05 | -1.14 |
| 2026-03-04 | -1.12 |
| 2026-03-03 | -1.17 |
| 2026-03-02 | -1.26 |
| 2026-02-27 | -1.21 |
| 2026-02-26 | -1.29 |
| 2026-02-25 | -1.19 |
| 2026-02-24 | -1.16 |
| 2026-02-23 | -1.14 |
| 2026-02-20 | -1.14 |
| 2026-02-19 | -1.12 |
| 2026-02-18 | -1.19 |
| 2026-02-17 | -1.18 |
| 2026-02-16 | -1.17 |
| 2026-02-13 | -1.24 |
| 2026-02-12 | -1.16 |
| 2026-02-11 | -1.20 |
| 2026-02-10 | -1.25 |
| 2026-02-09 | -1.16 |
| 2026-02-06 | -1.17 |
| 2026-02-05 | -1.24 |
| 2026-02-04 | -1.22 |
| 2026-02-03 | -1.26 |
| 2026-02-02 | -1.26 |
| 2026-01-30 | -1.25 |
| 2026-01-29 | -1.28 |
| 2026-01-28 | -1.30 |
| 2026-01-27 | -1.30 |
| 2026-01-26 | -1.41 |
| 2026-01-23 | -1.23 |
| 2026-01-22 | -1.14 |
| 2026-01-21 | -1.17 |
| 2026-01-20 | -1.17 |
| 2026-01-19 | -1.18 |
| 2026-01-16 | -1.16 |
| 2026-01-15 | -1.22 |
| 2026-01-14 | -1.18 |
| 2026-01-13 | -1.21 |
| 2026-01-12 | -1.21 |
| 2026-01-09 | -1.21 |
| 2026-01-08 | -1.20 |
| 2026-01-07 | -1.24 |